Advertisement

Molecular and Cellular Biochemistry

, Volume 435, Issue 1–2, pp 67–72 | Cite as

ENPP1 121Q functional variant enhances susceptibility to coronary artery disease in South Indian patients with type 2 diabetes mellitus

  • S. Sumi
  • Surya Ramachandran
  • V RamanKutty
  • Maulin M. Patel
  • T. N. Anand
  • Ajit S Mullasari
  • C. C. KarthaEmail author
Article

Abstract

Insulin resistance is associated with endothelial dysfunction and ensuing cardiovascular diseases in type 2 diabetes mellitus (T2DM) patients. ENPP1 is a key modulator of insulin signaling and its polymorphism, K121Q, increases the potency to competitively inhibit insulin receptor binding. We investigated the association of ENPP1 121Q variant with coronary artery disease (CAD) in patients with and without T2DM in South Indian population. Our study was conducted in 913 subjects: 198 patients with CAD, 284 patients in whom T2DM and CAD co-exists, 160 patients with T2DM and no CAD history, and 271 healthy volunteers. Genotyping was performed using PCR–RFLP and PCR-DNA sequencing. Genotype frequency of ENPP1 121Q was higher in disease groups compared to healthy subjects (p < 0.05). T2DM patients who carried polymorphic AC/CC genotypes were at 12.8-fold enhanced risk to CAD (95% CI 4.97–37.18, p < 0.01). Moreover we observed that 121Q, both in heterozygous and homozygous polymorphic states, was a risk factor for CAD without diabetes (OR 4.15, p < 0.01). 121Q variant was associated with T2DM patients with no CAD history too, but the risk was statistically insignificant after multivariate logistic regression analysis (OR 2.32, p > 0.05). We conclude that ENPP1 121Q variant is associated with increased risk for CAD in patients with T2DM in South Indian population. We also report that 121Q variant of ENPP1 was an independent risk factor for CAD irrespective of diabetic milieu. Factors which enhance insulin resistance increase the risk for onset and progression of coronary atherosclerosis irrespective of a diabetic background.

Keywords

Coronary artery disease Type 2 diabetes mellitus Prevalence Polymorphism ENPP1 South India 

Abbreviations

CAD

Coronary artery disease

T2DM

Type 2 diabetes mellitus

ENPP1

Ectoenzyme nucleotide pyrophosphate phosphodiesterase/plasma cell glycoprotein 1

FBS

Fasting blood sugar

HbA1c

Glycated haemoglobin

PCR–RFLP

Polymerase chain reaction-restriction fragment length polymorphism

OR

Odds ratio

CI

Confidence interval

Notes

Acknowledgements

We gratefully acknowledge Professor M Radhakrishna Pillai, Director, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram for providing funding and facilities for conducting this study. We also thank Dr. N S Pratapchandran and Dr. K R Santosh for providing patient samples. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Sumi S thankfully acknowledge DST WOS-A (SR/WOS-A/LS-1017/2014(G)) for research fellowship.

Authors’ contributions

SS, SR, and CCK conceived and designed the experiments, MMP, SS, and SR performed the experiments, VRK and ATN performed statistical analysis of data, VRK, AM, CCK provided reagents, materials, analysis tools, SS and SR prepared manuscript, AM and CCK critical review of manuscript. All authors read and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

All authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this research article.

Supplementary material

11010_2017_3057_MOESM1_ESM.pdf (228 kb)
Supplementary material 1 (PDF 227 kb)

References

  1. 1.
    Vijayakumar G, Arun R, Kutty VR (2009) High prevalence of type 2 diabetes mellitus and other metabolic disorders in rural Central Kerala. J Assoc Physicians India 57:563–567PubMedGoogle Scholar
  2. 2.
    Mohan V, Venkatraman JV, Pradeepa R (2010) Epidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario. J Diabetes Sci Technol 4:158–170CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Krishnan MN, Zachariah G, Venugopal K et al (2016) Prevalence of coronary artery disease and its risk factors in Kerala, South India: a community-based cross-sectional study. BMC Cardiovasc Disord 16:12. doi: 10.1186/s12872-016-0189-3 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Mohan V, Deepa R, Rani SS, Premalatha G (2001) Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 38:682–687CrossRefPubMedGoogle Scholar
  5. 5.
    Sousa AG, Selvatici L, Krieger JE, Pereira AC (2011) Association between genetics of diabetes, coronary artery disease, and macrovascular complications: exploring a common ground hypothesis. Rev Diabet Stud 8:230–244. doi: 10.1900/RDS.2011.8.230 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hadi HA, Carr CS, Al Suwaidi J (2005) Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 1:183–198PubMedPubMedCentralGoogle Scholar
  7. 7.
    Goldfine ID, Maddux BA, Youngren JF et al (2008) The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocr Rev 29:62–75. doi: 10.1210/er.2007-0004 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Abate N, Chandalia M, Satija P et al (2005) ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 54:1207–1213. doi: 10.2337/diabetes.54.4.1207 CrossRefPubMedGoogle Scholar
  9. 9.
    Bacci S, Ludovico O, Prudente S et al (2005) The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes 54:3021–3025. doi: 10.2337/diabetes.54.10.3021 CrossRefPubMedGoogle Scholar
  10. 10.
    Weedon MN, Shields B, Hitman G et al (2006) No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8089 U.K. Caucasians. Diabetes 55:3175–3179. doi: 10.2337/db06-0410 CrossRefPubMedGoogle Scholar
  11. 11.
    Bhatti JS, Bhatti GK, Mastana SS et al (2010) ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes in North Indians. Mol Cell Biochem 345:249–257. doi: 10.1007/s11010-010-0579-2 CrossRefPubMedGoogle Scholar
  12. 12.
    Ali S, Chopra R, Manvati S et al (2013) Replication of type 2 diabetes candidate genes variations in three geographically unrelated Indian population groups. PLoS ONE 8(3):e58881. doi: 10.1371/journal.pone.0058881 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tripathi AK, Shukla S, Dwivedi MK et al (2013) Obesity and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) polymorphism and their association with pathophysiology diabetes type 2 in Central Indian population. J Diabetes Endocrinol 4(2):19–26. doi: 10.5897/JDE12.018 Google Scholar
  14. 14.
    Bacci S, Rizza S, Prudente S et al (2011) The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes 60:1000–1007. doi: 10.2337/db10-1300 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Sumi S, Ramachandran S, Kutty VR et al (2015) Nonsynonymous T280M gene variant of CX3CR1 in South Indian population is associated with reduced risk for vascular disease in patients with diabetes mellitus. Curr Res 2:188–192Google Scholar
  16. 16.
    Buckley MF, Loveland KA, McKinstry WJ et al (1990) Plasma cell membrane glycoprotein PC-1. cDNA cloning of the human molecule, amino acid sequence, and chromosomal location. J Biol Chem 265:17506–17511PubMedGoogle Scholar
  17. 17.
    Sortica DA, Crispim D, Zaffari GP et al (2011) The role of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 in diabetic nephropathy. Arq Bras Endocrinol Metabol 55:677–685. doi: 10.1590/S0004-27302011000900002 CrossRefPubMedGoogle Scholar
  18. 18.
    Pizzuti A, Frittitta L, Argiolas A et al (1999) A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48:1881–1884. doi: 10.2337/diabetes.48.9.1881 CrossRefPubMedGoogle Scholar
  19. 19.
    Tang ST, Shen XR, Tang HQ et al (2014) Association of the ENPP1 K121Q polymorphism with susceptibility to type 2 diabetes in different populations: evidence based on 40 studies. Endocr J 61:1093–1103. doi: 10.1507/endocrj.EJ14-0272 CrossRefPubMedGoogle Scholar
  20. 20.
    Grarup N, Urhammer SA, Ek J et al (2006) Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia 49:2097–2104. doi: 10.1007/s00125-006-0353-x CrossRefPubMedGoogle Scholar
  21. 21.
    Lyon HN, Florez JC, Bersaglieri T et al (2006) Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes 55:3180–3184. doi: 10.2337/db06-0407 CrossRefPubMedGoogle Scholar
  22. 22.
    Murea M, Ma L, Freedman BI (2012) Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud 9:6–22. doi: 10.1900/RDS.2012.9.6 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Jeong DJ, Lee DG, Kim H-J et al (2010) ENPP1 K121Q genotype not associated with coronary artery calcification in Korean patients with type 2 diabetes mellitus. Korean Diabetes J 34:320–326. doi: 10.4093/kdj.2010.34.5.320 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • S. Sumi
    • 1
  • Surya Ramachandran
    • 1
  • V RamanKutty
    • 2
  • Maulin M. Patel
    • 1
  • T. N. Anand
    • 2
  • Ajit S Mullasari
    • 3
  • C. C. Kartha
    • 1
    Email author
  1. 1.Cardiovascular Diseases and Diabetes BiologyRajiv Gandhi Centre for BiotechnologyThiruvananthapuramIndia
  2. 2.Achutha Menon Centre for Health Science StudiesSree Chitra Tirunal Institute for Medical Sciences and TechnologyThiruvananthapuramIndia
  3. 3.Madras Medical MissionChennaiIndia

Personalised recommendations